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We thank the editor for the giving us the opportunity to respond to the points raised by 
Tomenson. Further, we would like to thank Tomenson for making publicly available parts of 
the so far unpublished report to the sponsors (the Titanium Dioxide Manufacturers Association, 
for which he provides consultancy services), including particularly the positive dose-response 
data for the French sub-cohort (re-analysed in our paper).1 
As clearly described in Methods and in Results of our short report, the cumulative exposure to 
TiO2 was lagged by 10 years. Obviously, this also affects the number of unexposed and 
exposed workers as reported in the supplemental Table S3.2 We recognize that we should have 
specified this also in the footnotes of that table.  
Regarding tobacco smoking, data were available for 201 (not only 33) workers at the second 
French plant and the combined crude smoking prevalence for the two French plants was 34%, 
compatible with the age-standardized prevalence of 42% reported by Boffetta et al.1 As 
discussed in our paper,2  we recognize that the reported prevalence of smoking was low, and 
lower than that estimated on the national level.  
As one part of our re-analysis, we used the available smoking data to explore potential 
confounding via multiple imputation for missing data, hough we had to assume that data were 
missing at random. Given the relatively small number of cases, a complete case analysis (as 
suggested by Tomenson) would be much less informative.  
In our re-analysis we found no evidence for confounding by smoking. Further, indirect methods 
support the notion that the observed positive dose-re ponse relationship cannot be entirely 
explained by confounding due to smoking.3  
Finally, we do not think that the increased risk among workers exposed to TiO2 or the positive 
dose-response relationship would be due to a low mortality rate in the unexposed workers. 
Using the low exposure group as reference would stil result in the same pattern and in an 
increased risk in the highest exposure group. We not that a dose-response relationship was 
also apparent in the original report from Boffetta et al.,1 who used different cut-points for 
exposure categories. Because of methodological limitations of the published TiO2 cohorts4 we 
cannot support Tomenson’s statement that there is  “considerable weight of evidence from 3 
large cohorts of no exposure-response”.  
We agree that our results need to be confirmed using a different analytical approach. We 
propose to reanalyse the available European TiO2 worker data using G methods5 to assess a 
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